Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

Additional Metadata
Keywords	BRCA1, BRCA2, Breast cancer survival, Familial cancer syndromes, Screening
Persistent URL	doi.org/10.1002/ijc.29534, hdl.handle.net/1765/91985
Journal	International Journal of Cancer
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Saadatmand, S., Obdeijn, I.-M., Rutgers, E., Oosterwijk, J., Tollenaar, R., Woldringh, G. H., Bergers, E., Verhoef, K., Heijnsdijk, E., Hooning, M., de Koning, H.& Tilanus-Linthorst, M. (2015). Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). International Journal of Cancer.https://doi.org/10.1002/ijc.29534

Publication